Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Luke

Showing results (171-180 of 356) with videos related to

Pageof 36
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2024
Do HIV Care Outcomes Differ by Provider Type?John Weiser, Yunfeng Tie, Stacy M Crim, et al.
Pharmacotherapy|January 1, 1991
Therapeutic drug monitoring of cyclosporine-lipoprotein levelsJ C Yau, L J Brunner, G Lopez-Berestein, et al.
Pediatric Neurology|January 23, 2013
Atypical imaging evolution of sturge-weber syndrome without facial nevusRebecca R Luke, Saleem I Malik, Angel W Hernandez, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
Antioxidants (Basel, Switzerland)|October 24, 2020
Defining the Functional Targets of Cap'n'collar Transcription Factors NRF1, NRF2, and NRF3Lara Ibrahim, Jaleh Mesgarzadeh, Ian Xu, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
BMC Infectious Diseases|January 17, 2013
Evaluation of intravenous voriconazole in patients with compromised renal functionCraig M Lilly, Verna L Welch, Thomas Mayer, et al.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2018
Differences in Characteristics and Clinical Outcomes Among Hispanic/Latino Men and Women Receiving HIV Medical Care - United States, 2013-2014Ruth E Luna-Gierke, R Luke Shouse, Qingwei Luo, et al.
Israel Journal of Chemistry|May 15, 2025
Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and ActivationJessica D Rosarda, Caroline R Stanton, Emily B Chen, et al.
The Journal of Biological Chemistry|November 26, 2002
GRIP domain-mediated targeting of two new coiled-coil proteins, GCC88 and GCC185, to subcompartments of the trans-Golgi networkMichael R Luke, Lars Kjer-Nielsen, Darren L Brown, et al.
Pageof 36

Showing results (171-180 of 356) with videos related to

Sort By:
Pageof 36
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2024
Do HIV Care Outcomes Differ by Provider Type?John Weiser, Yunfeng Tie, Stacy M Crim, et al.
Pharmacotherapy|January 1, 1991
Therapeutic drug monitoring of cyclosporine-lipoprotein levelsJ C Yau, L J Brunner, G Lopez-Berestein, et al.
Pediatric Neurology|January 23, 2013
Atypical imaging evolution of sturge-weber syndrome without facial nevusRebecca R Luke, Saleem I Malik, Angel W Hernandez, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
Antioxidants (Basel, Switzerland)|October 24, 2020
Defining the Functional Targets of Cap'n'collar Transcription Factors NRF1, NRF2, and NRF3Lara Ibrahim, Jaleh Mesgarzadeh, Ian Xu, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
BMC Infectious Diseases|January 17, 2013
Evaluation of intravenous voriconazole in patients with compromised renal functionCraig M Lilly, Verna L Welch, Thomas Mayer, et al.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2018
Differences in Characteristics and Clinical Outcomes Among Hispanic/Latino Men and Women Receiving HIV Medical Care - United States, 2013-2014Ruth E Luna-Gierke, R Luke Shouse, Qingwei Luo, et al.
Israel Journal of Chemistry|May 15, 2025
Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and ActivationJessica D Rosarda, Caroline R Stanton, Emily B Chen, et al.
The Journal of Biological Chemistry|November 26, 2002
GRIP domain-mediated targeting of two new coiled-coil proteins, GCC88 and GCC185, to subcompartments of the trans-Golgi networkMichael R Luke, Lars Kjer-Nielsen, Darren L Brown, et al.
Pageof 36